Defining super-enhancer landscape in triple-negative breast cancer

$ 20.00

4.9
(301)
In stock
Description

Rewiring of the 3D genome during acquisition of carboplatin resistance in a triple-negative breast cancer patient-derived xenograft

Research articles Nature Communications

Super-Enhancer Redistribution as a Mechanism of Broad Gene Dysregulation in Repeatedly Drug-Treated Cancer Cells - ScienceDirect

TCOF1 upregulation in triple-negative breast cancer promotes

Cancers, Free Full-Text

Nanomaterial-assisted CRISPR gene-engineering – A hallmark for triple-negative breast cancer therapeutics advancement - ScienceDirect

IJMS, Free Full-Text

PDF) Genome-wide chromatin accessibility, DNA methylation and gene

Super-enhancer acquisition drives oncogene expression in triple negative breast cancer

Cancers, Free Full-Text

IJMS, Free Full-Text

Super-enhancers complexes zoom in transcription in cancer, Journal of Experimental & Clinical Cancer Research

Frontiers Triple-negative breast cancer: from none to multiple

Prevalence and prognostic role of PIK3CA mutations. (a) Bar graph

Heterogeneity and transcriptional drivers of triple-negative breast cancer - ScienceDirect